IHAM
BHVN icon

Integral Health Asset Management’s Biohaven BHVN Stock Holding History

Integral Health Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
700,000
-300,000
-30% -$3.23M 0.41% 59
2026
Q1 		$8.46M Sell
1,000,000
-500,000
-33% -$5.47M 0.4% 66
2025
Q4 		$16.9M Buy
1,500,000
+850,000
+131% +$10.5M 0.84% 43
2025
Q3 		$9.76M Buy
650,000
+350,000
+117% +$5.09M 0.66% 53
2025
Q2 		$4.23M Buy
300,000
+125,000
+71% +$2.23M 0.39% 60
2025
Q1 		$4.21M Buy
+175,000
New +$6.17M 0.45% 57

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integral Health Asset Management's BHVN Position: Q2 2026 in Review

Integral Health Asset Management reduced its Biohaven (BHVN) stake by 30% in Q2 2026, selling an estimated $3.23M and leaving 700,000 shares worth $10.4M. The position accounts for 0.41% of the portfolio, ranked #59.

Integral Health Asset Management first reported a position in BHVN in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.9M in Q4 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Integral Health Asset Management held 700,000 shares of Biohaven worth $10.4M as of Q2 2026.
  • Integral Health Asset Management sold 300,000 Biohaven shares in Q2 2026, an estimated $3.23M.
  • Biohaven made up 0.41% of Integral Health Asset Management's portfolio in Q2 2026, its #59 holding.
  • Integral Health Asset Management first reported a position in Biohaven in Q1 2025 and has held it in 6 quarters since.
  • Integral Health Asset Management's Biohaven position peaked at $16.9M in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.